Strains are clear – costs of the bankruptcy case following 900 sex abuse claims against the Buffalo Diocese, a decrease in subsidies by the diocese and steep enrollment declines over
BrainStorm Cell Therapeutics Appoints Bob Dagher, M D , as Executive Vice President and Chief Development Officer tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Dr. Eid joins Dragonfly after 20 years of clinical development experience at Roche, Merck and BMS including as team leader at Merck in the Pembrolizumab (anti-PD-1 antibody) first in human trial
/PRNewswire/ Dragonfly Therapeutics, Inc., a clinical stage biotechnology company developing novel immunotherapies, today announced that Joseph E. Eid,.